Schulhoff & CO Inc Pyxis Oncology, Inc. Transaction History
Schulhoff & CO Inc
- $208 Million
- Q2 2025
A detailed history of Schulhoff & CO Inc transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Schulhoff & CO Inc holds 275,000 shares of PYXS stock, worth $500,500. This represents 0.15% of its overall portfolio holdings.
Number of Shares
275,000
Previous 122,000
125.41%
Holding current value
$500,500
Previous $119,000
153.78%
% of portfolio
0.15%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$6.6 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$6.44 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$5.07 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$4.55 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$3.91 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $63.9M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...